/
Real-world treatment patterns and outcomes for patients with CLL using the Australian pharmaceutical benefits scheme (PBS) dataset
- Tam, Constantine, Zhao, Fei-Li, Azam, Safee, Li, Shu Chuen, Tang, Boxiong
International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL
- Awan, Farrukh T., Addison, Daniel, Tam, Constantine, Ysebaert, Loïc, Alfraih, Feras, Baratta, Sergio J., Campos, Rodrigo Noronha, Cugliari, María Silvana, Goh, Yeow Tee, Ionin, Valery Alexandrovich, Mundnich, Stefanie, Sverdlov, Aaron L.
Are you sure you would like to clear your session, including search history and login status?